Intrathecal Drug Delivery System: A Pain Management Option for Refractory Cancer-Related Pain

Pain Med. 2021 Feb 23;22(2):523-526. doi: 10.1093/pm/pnaa364.

Abstract

Cancer-related pain is progressive and therefore requires a stepwise approach to management, such as the World Health Organization's Pain Ladder. This approach calls for increasingly strong pain medications in addition to interventional options for patients with medication-refractory pain or intolerable medication side effects. Here, we discuss a case involving cancer-related pain which ultimately required intrathecal drug delivery system placement for optimal pain management.

Keywords: Cancer Pain; Intrathecal Drug Delivery System; Opioids.

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Cancer Pain* / drug therapy
  • Drug Delivery Systems
  • Humans
  • Injections, Spinal
  • Neoplasms* / complications
  • Neoplasms* / drug therapy
  • Pain Management
  • Pain Measurement
  • Pain, Intractable* / drug therapy
  • Pain, Intractable* / etiology

Substances

  • Analgesics, Opioid